カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

カリウム競合拮抗薬のグローバル市場2023：スクラルファート、カリウム競合性酸ブロッカー

■ 英語タイトル：Global Potassium Competitive Antagonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG11526）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG11526
■ 発行日：2023年8月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：108
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[カリウム競合拮抗薬のグローバル市場2023：スクラルファート、カリウム競合性酸ブロッカー]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、カリウム競合拮抗薬のグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界のカリウム競合拮抗薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- カリウム競合拮抗薬の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

カリウム競合拮抗薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・スクラルファート、カリウム競合性酸ブロッカー

用途別セグメント
・病院、薬局、診療所、その他

主要な市場プレーヤー
・AstraZeneca Pharmaceuticals、Pfizer、Novartis Pharmaceuticals Corporation、Merck & Co、Bayer Pharmaceuticals Corporation、Lexicon Pharmaceuticals、Allergan、Roche、Teva Pharmaceuticals、Eli Lilly and Company、Sanofi

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、カリウム競合拮抗薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なカリウム競合拮抗薬メーカーの企業概要、2019年～2022年までのカリウム競合拮抗薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なカリウム競合拮抗薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別カリウム競合拮抗薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのカリウム競合拮抗薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのカリウム競合拮抗薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびカリウム競合拮抗薬の産業チェーンを掲載しています。
・第14、15章では、カリウム競合拮抗薬の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– カリウム競合拮抗薬の概要
– 種類別分析（2018年vs2022年vs2029年）：スクラルファート、カリウム競合性酸ブロッカー
– 用途別分析（2018年vs2022年vs2029年）：病院、薬局、診療所、その他
– 世界のカリウム競合拮抗薬市場規模・予測
– 世界のカリウム競合拮抗薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– AstraZeneca Pharmaceuticals、Pfizer、Novartis Pharmaceuticals Corporation、Merck & Co、Bayer Pharmaceuticals Corporation、Lexicon Pharmaceuticals、Allergan、Roche、Teva Pharmaceuticals、Eli Lilly and Company、Sanofi
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：スクラルファート、カリウム競合性酸ブロッカー
・用途別分析2018年-2029年：病院、薬局、診療所、その他
・カリウム競合拮抗薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・カリウム競合拮抗薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・カリウム競合拮抗薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・カリウム競合拮抗薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・カリウム競合拮抗薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Potassium Competitive Antagonist
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Potassium Competitive Antagonist Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Sucralfate
1.3.3 Potassium-competitive Acid Blockers
1.4 Market Analysis by Application
1.4.1 Overview: Global Potassium Competitive Antagonist Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Clinic
1.4.5 Others
1.5 Global Potassium Competitive Antagonist Market Size & Forecast
1.5.1 Global Potassium Competitive Antagonist Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Potassium Competitive Antagonist Sales Quantity (2018-2029)
1.5.3 Global Potassium Competitive Antagonist Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AstraZeneca Pharmaceuticals
2.1.1 AstraZeneca Pharmaceuticals Details
2.1.2 AstraZeneca Pharmaceuticals Major Business
2.1.3 AstraZeneca Pharmaceuticals Potassium Competitive Antagonist Product and Services
2.1.4 AstraZeneca Pharmaceuticals Potassium Competitive Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AstraZeneca Pharmaceuticals Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Potassium Competitive Antagonist Product and Services
2.2.4 Pfizer Potassium Competitive Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 Novartis Pharmaceuticals Corporation
2.3.1 Novartis Pharmaceuticals Corporation Details
2.3.2 Novartis Pharmaceuticals Corporation Major Business
2.3.3 Novartis Pharmaceuticals Corporation Potassium Competitive Antagonist Product and Services
2.3.4 Novartis Pharmaceuticals Corporation Potassium Competitive Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Pharmaceuticals Corporation Recent Developments/Updates
2.4 Merck & Co
2.4.1 Merck & Co Details
2.4.2 Merck & Co Major Business
2.4.3 Merck & Co Potassium Competitive Antagonist Product and Services
2.4.4 Merck & Co Potassium Competitive Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck & Co Recent Developments/Updates
2.5 Bayer Pharmaceuticals Corporation
2.5.1 Bayer Pharmaceuticals Corporation Details
2.5.2 Bayer Pharmaceuticals Corporation Major Business
2.5.3 Bayer Pharmaceuticals Corporation Potassium Competitive Antagonist Product and Services
2.5.4 Bayer Pharmaceuticals Corporation Potassium Competitive Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bayer Pharmaceuticals Corporation Recent Developments/Updates
2.6 Lexicon Pharmaceuticals
2.6.1 Lexicon Pharmaceuticals Details
2.6.2 Lexicon Pharmaceuticals Major Business
2.6.3 Lexicon Pharmaceuticals Potassium Competitive Antagonist Product and Services
2.6.4 Lexicon Pharmaceuticals Potassium Competitive Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Lexicon Pharmaceuticals Recent Developments/Updates
2.7 Allergan
2.7.1 Allergan Details
2.7.2 Allergan Major Business
2.7.3 Allergan Potassium Competitive Antagonist Product and Services
2.7.4 Allergan Potassium Competitive Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Allergan Recent Developments/Updates
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Potassium Competitive Antagonist Product and Services
2.8.4 Roche Potassium Competitive Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Roche Recent Developments/Updates
2.9 Teva Pharmaceuticals
2.9.1 Teva Pharmaceuticals Details
2.9.2 Teva Pharmaceuticals Major Business
2.9.3 Teva Pharmaceuticals Potassium Competitive Antagonist Product and Services
2.9.4 Teva Pharmaceuticals Potassium Competitive Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Teva Pharmaceuticals Recent Developments/Updates
2.10 Eli Lilly and Company
2.10.1 Eli Lilly and Company Details
2.10.2 Eli Lilly and Company Major Business
2.10.3 Eli Lilly and Company Potassium Competitive Antagonist Product and Services
2.10.4 Eli Lilly and Company Potassium Competitive Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eli Lilly and Company Recent Developments/Updates
2.11 Sanofi
2.11.1 Sanofi Details
2.11.2 Sanofi Major Business
2.11.3 Sanofi Potassium Competitive Antagonist Product and Services
2.11.4 Sanofi Potassium Competitive Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sanofi Recent Developments/Updates
3 Competitive Environment: Potassium Competitive Antagonist by Manufacturer
3.1 Global Potassium Competitive Antagonist Sales Quantity by Manufacturer (2018-2023)
3.2 Global Potassium Competitive Antagonist Revenue by Manufacturer (2018-2023)
3.3 Global Potassium Competitive Antagonist Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Potassium Competitive Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Potassium Competitive Antagonist Manufacturer Market Share in 2022
3.4.2 Top 6 Potassium Competitive Antagonist Manufacturer Market Share in 2022
3.5 Potassium Competitive Antagonist Market: Overall Company Footprint Analysis
3.5.1 Potassium Competitive Antagonist Market: Region Footprint
3.5.2 Potassium Competitive Antagonist Market: Company Product Type Footprint
3.5.3 Potassium Competitive Antagonist Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Potassium Competitive Antagonist Market Size by Region
4.1.1 Global Potassium Competitive Antagonist Sales Quantity by Region (2018-2029)
4.1.2 Global Potassium Competitive Antagonist Consumption Value by Region (2018-2029)
4.1.3 Global Potassium Competitive Antagonist Average Price by Region (2018-2029)
4.2 North America Potassium Competitive Antagonist Consumption Value (2018-2029)
4.3 Europe Potassium Competitive Antagonist Consumption Value (2018-2029)
4.4 Asia-Pacific Potassium Competitive Antagonist Consumption Value (2018-2029)
4.5 South America Potassium Competitive Antagonist Consumption Value (2018-2029)
4.6 Middle East and Africa Potassium Competitive Antagonist Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Potassium Competitive Antagonist Sales Quantity by Type (2018-2029)
5.2 Global Potassium Competitive Antagonist Consumption Value by Type (2018-2029)
5.3 Global Potassium Competitive Antagonist Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Potassium Competitive Antagonist Sales Quantity by Application (2018-2029)
6.2 Global Potassium Competitive Antagonist Consumption Value by Application (2018-2029)
6.3 Global Potassium Competitive Antagonist Average Price by Application (2018-2029)
7 North America
7.1 North America Potassium Competitive Antagonist Sales Quantity by Type (2018-2029)
7.2 North America Potassium Competitive Antagonist Sales Quantity by Application (2018-2029)
7.3 North America Potassium Competitive Antagonist Market Size by Country
7.3.1 North America Potassium Competitive Antagonist Sales Quantity by Country (2018-2029)
7.3.2 North America Potassium Competitive Antagonist Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Potassium Competitive Antagonist Sales Quantity by Type (2018-2029)
8.2 Europe Potassium Competitive Antagonist Sales Quantity by Application (2018-2029)
8.3 Europe Potassium Competitive Antagonist Market Size by Country
8.3.1 Europe Potassium Competitive Antagonist Sales Quantity by Country (2018-2029)
8.3.2 Europe Potassium Competitive Antagonist Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Potassium Competitive Antagonist Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Potassium Competitive Antagonist Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Potassium Competitive Antagonist Market Size by Region
9.3.1 Asia-Pacific Potassium Competitive Antagonist Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Potassium Competitive Antagonist Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Potassium Competitive Antagonist Sales Quantity by Type (2018-2029)
10.2 South America Potassium Competitive Antagonist Sales Quantity by Application (2018-2029)
10.3 South America Potassium Competitive Antagonist Market Size by Country
10.3.1 South America Potassium Competitive Antagonist Sales Quantity by Country (2018-2029)
10.3.2 South America Potassium Competitive Antagonist Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Potassium Competitive Antagonist Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Potassium Competitive Antagonist Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Potassium Competitive Antagonist Market Size by Country
11.3.1 Middle East & Africa Potassium Competitive Antagonist Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Potassium Competitive Antagonist Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Potassium Competitive Antagonist Market Drivers
12.2 Potassium Competitive Antagonist Market Restraints
12.3 Potassium Competitive Antagonist Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Potassium Competitive Antagonist and Key Manufacturers
13.2 Manufacturing Costs Percentage of Potassium Competitive Antagonist
13.3 Potassium Competitive Antagonist Production Process
13.4 Potassium Competitive Antagonist Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Potassium Competitive Antagonist Typical Distributors
14.3 Potassium Competitive Antagonist Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Potassium Competitive Antagonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Potassium Competitive Antagonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AstraZeneca Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Pharmaceuticals Major Business
Table 5. AstraZeneca Pharmaceuticals Potassium Competitive Antagonist Product and Services
Table 6. AstraZeneca Pharmaceuticals Potassium Competitive Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AstraZeneca Pharmaceuticals Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Potassium Competitive Antagonist Product and Services
Table 11. Pfizer Potassium Competitive Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Recent Developments/Updates
Table 13. Novartis Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Pharmaceuticals Corporation Major Business
Table 15. Novartis Pharmaceuticals Corporation Potassium Competitive Antagonist Product and Services
Table 16. Novartis Pharmaceuticals Corporation Potassium Competitive Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis Pharmaceuticals Corporation Recent Developments/Updates
Table 18. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 19. Merck & Co Major Business
Table 20. Merck & Co Potassium Competitive Antagonist Product and Services
Table 21. Merck & Co Potassium Competitive Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck & Co Recent Developments/Updates
Table 23. Bayer Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Bayer Pharmaceuticals Corporation Major Business
Table 25. Bayer Pharmaceuticals Corporation Potassium Competitive Antagonist Product and Services
Table 26. Bayer Pharmaceuticals Corporation Potassium Competitive Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Bayer Pharmaceuticals Corporation Recent Developments/Updates
Table 28. Lexicon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Lexicon Pharmaceuticals Major Business
Table 30. Lexicon Pharmaceuticals Potassium Competitive Antagonist Product and Services
Table 31. Lexicon Pharmaceuticals Potassium Competitive Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Lexicon Pharmaceuticals Recent Developments/Updates
Table 33. Allergan Basic Information, Manufacturing Base and Competitors
Table 34. Allergan Major Business
Table 35. Allergan Potassium Competitive Antagonist Product and Services
Table 36. Allergan Potassium Competitive Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Allergan Recent Developments/Updates
Table 38. Roche Basic Information, Manufacturing Base and Competitors
Table 39. Roche Major Business
Table 40. Roche Potassium Competitive Antagonist Product and Services
Table 41. Roche Potassium Competitive Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Roche Recent Developments/Updates
Table 43. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Teva Pharmaceuticals Major Business
Table 45. Teva Pharmaceuticals Potassium Competitive Antagonist Product and Services
Table 46. Teva Pharmaceuticals Potassium Competitive Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Teva Pharmaceuticals Recent Developments/Updates
Table 48. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 49. Eli Lilly and Company Major Business
Table 50. Eli Lilly and Company Potassium Competitive Antagonist Product and Services
Table 51. Eli Lilly and Company Potassium Competitive Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Eli Lilly and Company Recent Developments/Updates
Table 53. Sanofi Basic Information, Manufacturing Base and Competitors
Table 54. Sanofi Major Business
Table 55. Sanofi Potassium Competitive Antagonist Product and Services
Table 56. Sanofi Potassium Competitive Antagonist Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Sanofi Recent Developments/Updates
Table 58. Global Potassium Competitive Antagonist Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Potassium Competitive Antagonist Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Potassium Competitive Antagonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Potassium Competitive Antagonist, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Potassium Competitive Antagonist Production Site of Key Manufacturer
Table 63. Potassium Competitive Antagonist Market: Company Product Type Footprint
Table 64. Potassium Competitive Antagonist Market: Company Product Application Footprint
Table 65. Potassium Competitive Antagonist New Market Entrants and Barriers to Market Entry
Table 66. Potassium Competitive Antagonist Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Potassium Competitive Antagonist Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Potassium Competitive Antagonist Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Potassium Competitive Antagonist Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Potassium Competitive Antagonist Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Potassium Competitive Antagonist Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Potassium Competitive Antagonist Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Potassium Competitive Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Potassium Competitive Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Potassium Competitive Antagonist Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Potassium Competitive Antagonist Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Potassium Competitive Antagonist Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Potassium Competitive Antagonist Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Potassium Competitive Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Potassium Competitive Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Potassium Competitive Antagonist Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Potassium Competitive Antagonist Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Potassium Competitive Antagonist Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Potassium Competitive Antagonist Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Potassium Competitive Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Potassium Competitive Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Potassium Competitive Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Potassium Competitive Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Potassium Competitive Antagonist Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Potassium Competitive Antagonist Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Potassium Competitive Antagonist Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Potassium Competitive Antagonist Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Potassium Competitive Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Potassium Competitive Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Potassium Competitive Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Potassium Competitive Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Potassium Competitive Antagonist Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Potassium Competitive Antagonist Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Potassium Competitive Antagonist Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Potassium Competitive Antagonist Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Potassium Competitive Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Potassium Competitive Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Potassium Competitive Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Potassium Competitive Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Potassium Competitive Antagonist Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Potassium Competitive Antagonist Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Potassium Competitive Antagonist Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Potassium Competitive Antagonist Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Potassium Competitive Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Potassium Competitive Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Potassium Competitive Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Potassium Competitive Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Potassium Competitive Antagonist Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Potassium Competitive Antagonist Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Potassium Competitive Antagonist Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Potassium Competitive Antagonist Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Potassium Competitive Antagonist Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Potassium Competitive Antagonist Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Potassium Competitive Antagonist Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Potassium Competitive Antagonist Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Potassium Competitive Antagonist Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Potassium Competitive Antagonist Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Potassium Competitive Antagonist Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Potassium Competitive Antagonist Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Potassium Competitive Antagonist Raw Material
Table 126. Key Manufacturers of Potassium Competitive Antagonist Raw Materials
Table 127. Potassium Competitive Antagonist Typical Distributors
Table 128. Potassium Competitive Antagonist Typical Customers
List of Figures
Figure 1. Potassium Competitive Antagonist Picture
Figure 2. Global Potassium Competitive Antagonist Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Potassium Competitive Antagonist Consumption Value Market Share by Type in 2022
Figure 4. Sucralfate Examples
Figure 5. Potassium-competitive Acid Blockers Examples
Figure 6. Global Potassium Competitive Antagonist Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Potassium Competitive Antagonist Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Pharmacy Examples
Figure 10. Clinic Examples
Figure 11. Others Examples
Figure 12. Global Potassium Competitive Antagonist Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Potassium Competitive Antagonist Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Potassium Competitive Antagonist Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Potassium Competitive Antagonist Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Potassium Competitive Antagonist Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Potassium Competitive Antagonist Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Potassium Competitive Antagonist by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Potassium Competitive Antagonist Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Potassium Competitive Antagonist Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Potassium Competitive Antagonist Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Potassium Competitive Antagonist Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Potassium Competitive Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Potassium Competitive Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Potassium Competitive Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Potassium Competitive Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Potassium Competitive Antagonist Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Potassium Competitive Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Potassium Competitive Antagonist Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Potassium Competitive Antagonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Potassium Competitive Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Potassium Competitive Antagonist Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Potassium Competitive Antagonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Potassium Competitive Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Potassium Competitive Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Potassium Competitive Antagonist Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Potassium Competitive Antagonist Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Potassium Competitive Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Potassium Competitive Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Potassium Competitive Antagonist Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Potassium Competitive Antagonist Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Potassium Competitive Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Potassium Competitive Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Potassium Competitive Antagonist Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Potassium Competitive Antagonist Consumption Value Market Share by Region (2018-2029)
Figure 54. China Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Potassium Competitive Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Potassium Competitive Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Potassium Competitive Antagonist Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Potassium Competitive Antagonist Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Potassium Competitive Antagonist Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Potassium Competitive Antagonist Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Potassium Competitive Antagonist Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Potassium Competitive Antagonist Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Potassium Competitive Antagonist Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Potassium Competitive Antagonist Market Drivers
Figure 75. Potassium Competitive Antagonist Market Restraints
Figure 76. Potassium Competitive Antagonist Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Potassium Competitive Antagonist in 2022
Figure 79. Manufacturing Process Analysis of Potassium Competitive Antagonist
Figure 80. Potassium Competitive Antagonist Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • バソプレシン拮抗薬のグローバル市場2023：ヴァプリゾール、トルバプタン
  • アンドロゲン受容体拮抗薬のグローバル市場2023：第一世代阻害剤、第二世代阻害剤
  • クラブラン酸カリウムAPIのグローバル市場2023：純度99%以上、純度99%以下
  • オピエートきっ抗剤のグローバル市場展望 2023年-2029年：0.4mg/ml、1mg/ml、2mg/ml
  • 二塩基性-リン酸カリウム-無水物のグローバル市場2023：USP、EP、BP
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG11526 )"カリウム競合拮抗薬のグローバル市場2023：スクラルファート、カリウム競合性酸ブロッカー" (英文：Global Potassium Competitive Antagonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。